Understanding Differences in Enrollment Outcomes among Diverse, High-Risk Populations Recruited to a Phase IIb HIV Vaccine Trial

被引：0
|
作者：
Frew, P. M. [1 ]
Clifton, S. [1 ]
Lu, L. [1 ]
del Rio, C. [1 ]
Mulligan, M. J. [1 ]
机构：
[1] Emory Univ, Decatur, GA USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2008年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [1] Understanding Differences in Enrollment Outcomes Among High-Risk Populations Recruited to a Phase IIb HIV Vaccine Trial
    Frew, Paula M.
    del Rio, Carlos
    Lu, Lu
    Clifton, Sarah
    Mulligan, Mark J.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (03) : 314 - 319
  • [2] Determinants of Enrollment in a Phase-IIb Prophylactic HIV Vaccine Trial in Canada
    Newman, P. A.
    Cook, C.
    Daley, A.
    Yim, S.
    Halpenny, R.
    Loutfy, M.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 109 - 110
  • [3] Pregnancies among high-risk women in the first ever HIV vaccine efficacy trial
    Brown-Peterside, P
    Ren, L
    Hirsch, A
    Drucker, M
    Koblin, BA
    [J]. AIDS, 2003, 17 (05) : 787 - 788
  • [4] Predicting Hypothetical Willingness to Participate (WTP) in a Future Phase III HIV Vaccine Trial Among High-Risk Adolescents
    Georgina Giocos
    Ashraf Kagee
    Leslie Swartz
    [J]. AIDS and Behavior, 2008, 12 : 842 - 851
  • [5] Clusters of HIV transmission among high-risk populations in Pakistan
    Thompson, Laura H.
    Wertheim, Joel O.
    Reza, Tahira
    Wylie, John L.
    Emmanuel, Faran
    Brooks, James
    Blanchard, James F.
    Sandstrom, Paul
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
  • [6] Factors Associated with Willingness to Participate in HIV Vaccine Trials among High-Risk Populations in South India
    Suhadev, Mohanarani
    Nyamathi, Adeline M.
    Swaminathan, Soumya
    Suresh, Anitha
    Venkatesan, P.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (02) : 217 - 224
  • [7] Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials
    Koblin, BA
    Holte, S
    Lenderking, B
    Heagerty, P
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (05) : 451 - 457
  • [8] HIV and STI Risk among Single Mothers in Ndola and Lusaka, Zambia: Is HIV Incidence High Enough for Enrollment in a Vaccine Efficacy Trial?
    Filipowicz, Teresa
    Mulenga, Muyunda
    Parker, Rachel
    Smith, Kevin
    Cooper, Renee
    Sharkey, Tyronza
    Malama, Kalonde
    Tichacek, Amanda
    Matsoso, Mabela
    Price, Matt
    Inambao, Mubiana
    Kilembe, William
    Allen, Susan
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 371 - 371
  • [9] Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials
    Kebba, Anthony
    Imami, Nesrina
    Bugembe-Lule, Daniel
    Senkaali, David
    Kaleebu, Pontiano
    Grosskurth, Heiner
    Gotch, Frances
    [J]. PHARMACOGENOMICS, 2007, 8 (04) : 409 - 414
  • [10] HIV prevention fatigue among high-risk populations in San Francisco
    Stockman, JK
    Schwarez, SK
    Butler, LM
    de Jong, B
    Chen, SY
    Delgado, V
    McFarland, W
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (04) : 432 - 434
12345